RNAi Roundup: CytRx Names Full-time CFO; Genta to Enter RNAi Arena with Salus Acquisition; Nucleonics licenses RNAi Patent Applications from Wyeth; EURIT Sets Meeting for September 2 | GenomeWeb

NEW YORK, Aug. 22 (GenomeWeb News) - A year after it merged with Global Genomics, CytRx has found a permanent chief financial officer in Kirk Peacock, 35, who on Aug. 15 took the company's fiscal reins from interim-CFO and still-CEO Steve Kriegsman.   

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.